Masoud Dadashi
Overview
Explore the profile of Masoud Dadashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
743
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bostanshirin N, Hajikhani B, Vaezi A, Kermanian F, Sameni F, Yaslianifard S, et al.
Infect Agent Cancer
. 2023 Mar;
18(1):14.
PMID: 36859379
Background: Colorectal cancer (CRC) is considered the second-deadliest and third-most common malignancy worldwide. Studying the carcinogenic mechanism of bacteria or their role in aggravating cancer can be precious. Fusobacterium nucleatum...
12.
Daneshvar P, Hajikhani B, Sameni F, Noorisepehr N, Zare F, Bostanshirin N, et al.
Heliyon
. 2023 Feb;
9(2):e13637.
PMID: 36789387
Background And Aim: Coronavirus disease 2019 (COVID-19) coinfection with other respiratory pathogens poses a serious concern that can complicate diagnosis, treatment, and prognosis. Since COVID-19 and tuberculosis are both severe...
13.
Firoozeh F, Bakhshi F, Dadashi M, Badmasti F, Zibaei M, Omidinia N
Acta Microbiol Immunol Hung
. 2023 Jan;
70(1):22-28.
PMID: 36640263
Multidrug-resistant (MDR) Acinetobacter baumannii is a serious global health threat. Burn patients are at high risk to acquire A. baumannii infections from endogenous sources. This study evaluated carbapenem resistance and...
14.
Dadashi M, Dadashi A, Sameni F, Sayadi S, Goudarzi M, Nasiri M, et al.
Gene Rep
. 2022 May;
27:101624.
PMID: 35607389
Background And Aim: Coronavirus disease 2019 (COVID-19) in people living with human immunodeficiency virus (HIV) who has a compromised immune system can be associated with more significant risks for severe...
15.
Dashtbin S, Mirkalantari S, Dadashi M, Darban-Sarokhalil D
Expert Rev Anti Infect Ther
. 2022 Mar;
20(7):1015-1023.
PMID: 35306950
Introduction: (), a non-tuberculous mycobacterium (NTM), rare causes infection including localized pulmonary to disseminated disease in immunocompromised patients. An optimal pharmacological management practice has not yet been defined for this...
16.
Zamani S, Mohammadi A, Hajikhani B, Abiri P, Fazeli M, Nasiri M, et al.
Biomed Res Int
. 2022 Jan;
2022:7408029.
PMID: 35075429
The spread of mupirocin-resistant strains in hospitals and communities is a universal challenge. Limited data is available on the genetic features of high-level mupirocin resistant- (HLMUPR-) isolates in Tehran. In...
17.
Seyedjavadi S, Razzaghi-Abyaneh M, Nasiri M, Hashemi A, Goudarzi H, Haghighi M, et al.
Probiotics Antimicrob Proteins
. 2022 Jan;
14(2):326-336.
PMID: 35050481
Today, resistance of microorganisms to antibiotics has become a major challenge. To overcome this problem, development of new drugs, besides research on their antibacterial activity, is essential. Among chemical components,...
18.
Goudarzi M, Hajikhani B, Nasiri M, Goudarzi H, Dadashi M, Haghighi M, et al.
Acta Microbiol Immunol Hung
. 2021 Nov;
68(4):227-234.
PMID: 34806999
Staphylococcus aureus as an opportunistic bacterial pathogen with intrinsic and acquired resistance to many antibiotics is a worldwide problem. The current study was undertaken to evaluate the resistance pattern, and...
19.
Dadashi M, Sameni F, Bostanshirin N, Yaslianifard S, Khosravi-Dehaghi N, Nasiri M, et al.
J Glob Antimicrob Resist
. 2021 Nov;
29:444-461.
PMID: 34788692
Objectives: The continuing rise in infections caused by multidrug-resistant (MDR) bacteria is one of the most serious public-health issues in society today. Colistin is a last-resort antimicrobial drug used to...
20.
Bahraminia F, Azimi T, Zangiabadian M, Nasiri M, Goudarzi M, Dadashi M, et al.
Iran J Basic Med Sci
. 2021 Oct;
24(6):720-725.
PMID: 34630948
No abstract available.